The Valley Desk

NCT05319028 · Interventional trial

Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Overall registry status Terminated

Phase 2

Conditions Non-GCB/ABC Diffuse Large B-Cell Lymphoma, With and Without MyD88 and/or CD79B Mutations

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov